Tarquin Scadding News Today

This article addresses the need for updated maternity guidelines in healthcare, as highlighted by a report from the NHS Race and Health Observatory. The report emphasizes the inadequacy of the Apgar score, a health assessment tool for newborns, in addressing the diversity of skin colors among infants. Currently, the score focuses on assessing whether a baby's skin is pink, which is only relevant for white babies, potentially leading to inaccurate assessments and overlooking the healthcare n...

Mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022Recognized for championing diversity and collaboration within the clinical trials industry Bracknell, UK – 6 Sept 2022: LaQuinta Jernigan, Chief Operating Officer for mdgroup, has been recog...

/PRNewswire/ -- LaQuinta Jernigan, Chief Operating Officer for mdgroup, has been recognized as one of 100 most inspiring people in life sciences by a leading...

Mdgroup appoints LaQuinta Jernigan as Chief Operating OfficerExecutive leadership appointment to drive seamless client experiences in patient- servicing and digitally enabled clinical trialsBracknell, UK – 14 June 2022: mdgroup, the leading global digital and patient-health servicing company pioneering a patie...

Combining Passion for Nursing and Clinical Research to Provide Remarkable Patient Experiences BRACKNELL, England, Feb. 15, 2022 /PRNewswire/ -- mdgroup, the leading global provider of personalised

/PRNewswire/ -- mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named...

Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.

Alex Flynn was 36 when diagnosed with Parkinson’s in 2008 and has since raised around £400,000 in the last ten years - News - PharmaTimes

Alex Flynn was 36 when diagnosed with Parkinson’s in 2008 and has since raised around £400,000 in the last ten years - News - PharmaTimes